DR. EPSTEIN’S COMPREHENSIVE Breast Augmentation Guide

Intro to Breast Augmentation

Anesthesia – General, Sedation or Local?

Motiva® vs Other Breast Implants: Rupture, Capsular Contracture and Reoperation Rates Compared

Motiva vs Other Implants

Key Takeaways

  • All four silicone gel implant brands sold in the U.S. (Allergan Natrelle, Mentor, Sientra and Motiva®) are FDA approved. Motiva received FDA approval on September 26, 2024.
  • At 10 years, ruptures found by MRI occurred in about 9% of Allergan Natrelle and Sientra patients. Mentor reported 9.8% for ruptures confirmed when the implant was removed, and 24.2% when suspected ruptures seen on MRI are included.
  • At 5 years, Motiva's rupture rate was 0.6%, its capsular contracture rate was 0.5% and its reoperation rate was 8.8%.
  • Motiva's numbers are 5-year results from a 10-year study that began in May 2018. The other brands' numbers are 10-year results, so they are not a direct comparison.
  • Most ruptures found in these studies were silent. In the Mentor study, 75 of 77 ruptured implants caused no symptoms and were found only on MRI.
  • Implants do not need to be replaced every 10 years. I recommend an ultrasound 5 to 6 years after surgery and every 3 years after that, with an MRI if the ultrasound result is unclear.
  • No study has compared these brands head to head, and each study was sponsored by its manufacturer.

Safety Data at a Glance

 

Implant Follow-up Rupture Capsular contracture (Baker III/IV) Reoperation (any reason)
Allergan Natrelle (round) 10 years 9.3% 18.9% 36.1%
Mentor MemoryGel 10 years 9.8% confirmed at removal; 24.2% suspected or confirmed on MRI 12.1% 25.5%
Sientra 10 years 9% 13% 24%
Motiva® SmoothSilk® 5 years (10-year study ongoing) 0.6% 0.5% 8.8%

NOTE

Primary breast augmentation patients, per patient, from each manufacturer's FDA study. Allergan, Mentor and Sientra at 10 years; Motiva at 5 years of an ongoing 10-year study.

Can One Breast Implant Be Safer Than the Others?

I have been asked this question many times in my more than 30 years of practice. Every implant sold in the U.S. today is FDA approved, and every one of them is a safe device. Even so, the brands do differ in how often certain problems occur, and patients deserve clear numbers to help them decide.

Many patients think saline implants are safer than silicone because they contain salt water. In fact, all breast implants have a shell made of silicone. The shell is filled with either saline or silicone gel, so the body is exposed to silicone either way. Silicone gel implants feel far more natural and ripple much less than saline implants. I would not let my spouse and daughters have silicone gel implants if I had even the slightest concern about their long-term safety.

There is currently no published article in a peer-reviewed scientific journal that ties breast implants to any of the reported symptoms believed to be "breast implant illness." Textured breast implants, however, are associated with a rare lymphoma called BIA-ALCL, and macrotextured implants were removed from the U.S. market for that reason. Motiva SmoothSilk® implants have a very fine surface, and no BIA-ALCL cases were reported in the 5-year Motiva study.

Motiva vs Traditional Silicone Implants: How They Differ

 

Feature Motiva® implants Traditional silicone implants
Fill Cohesive silicone gel Cohesive silicone gel
Shell surface SmoothSilk® surface with a very fine surface structure Smooth silicone shell; design varies by manufacturer
Feel Designed for a soft, natural feel Varies with the brand and how firm the gel is
Movement Ergonomix® is designed to change shape with body position and movement Depends on the specific implant design
FDA status FDA approved September 26, 2024 FDA approved
U.S. study follow-up 5-year results published; 10-year study ongoing 10-year results published
Choosing an implant Depends on your anatomy, tissue, goals and the specific Motiva implant Depends on your anatomy, tissue, goals and the implant design

 

The Three Numbers That Matter Most

When I compare implants, I look at three safety measures from each manufacturer's FDA study: how often the implant ruptures, how often capsular contracture develops, and how often patients need another operation. The sections below look at each one.

Rupture Rates

A rupture means the implant shell has a tear or opening. Implants are mechanical devices and will not last forever, but there is no set time when they must be replaced. Today's cohesive silicone gel tends to stay in place when the shell breaks, so most ruptures cause no symptoms. In the FDA studies, patients had scheduled MRI scans, which is how most ruptures were found.

 

Implant Follow-up Rupture rate How rupture was counted
Allergan Natrelle (round) 10 years 9.3% Rupture diagnosed on MRI
Mentor MemoryGel 10 years 9.8% Rupture confirmed when the implant was removed
Mentor MemoryGel 10 years 24.2% Rupture suspected or confirmed on MRI
Sientra 10 years 9% From Sientra's patient labeling, 10-year data
Motiva® SmoothSilk® 5 years 0.6% Rupture suspected or confirmed on MRI

NOTE

All figures are per patient, primary augmentation. Mentor reported two rupture numbers depending on whether suspected ruptures seen on MRI were counted, so both are shown.

Most ruptures are silent

In the Mentor study, 75 of the 77 ruptured implants were silent, meaning they caused no symptoms and were found only on MRI. The rate of ruptures that actually caused symptoms was 0.6% at 10 years. A rupture found on a scan is worth evaluating, but it is usually not an emergency.

Why Motiva's 0.6% is a 5-year number

Rupture rates rise as implants get older, for every brand. Motiva's 0.6% comes from the first 5 years of a 10-year study, while the other brands' numbers are from 10 years. The Motiva results so far are very encouraging, but the fairest comparison will come when the 10-year data is available.

Capsular Contracture Rates

A thin layer of tissue, called a capsule, forms around every implant. Capsular contracture happens when that capsule thickens and tightens, which can make the breast feel firm or hard and can push the implant upward. Baker grade III and IV contracture is the kind patients can see or feel, and it often needs treatment.

 

Implant Follow-up Capsular contracture (Baker III/IV)
Allergan Natrelle (round) 10 years 18.9%
Mentor MemoryGel 10 years 12.1%
Sientra 10 years 13%
Motiva® SmoothSilk® 5 years 0.5%

NOTE

Per patient, primary augmentation, from each manufacturer's FDA study.

Reoperation Rates

The reoperation rate is how often a patient had another operation for any reason. Many reasons have nothing to do with the implant itself, such as choosing a different size. Others do relate to the implant, such as rupture, capsular contracture, or the implant settling too low or to the side. In the Motiva study, the most common reasons for reoperation were a change in size and implant position, not rupture or capsular contracture.

Implant Follow-up Reoperation (any reason)
Allergan Natrelle (round) 10 years 36.1%
Mentor MemoryGel 10 years 25.5%
Sientra 10 years 24%
Motiva® SmoothSilk® 5 years 8.8%

NOTE

Per patient, primary augmentation. Reoperation rates for revision patients are higher for every brand. For Motiva, the 5-year reoperation rate in revision patients was 36.0%.

How to Compare Implant Safety Data Fairly

  • Check the follow-up time. A 5-year rate cannot be compared directly with a 10-year rate.
  • Check how the event was counted. As the Mentor study shows, rupture rates change a lot depending on whether suspected ruptures are included.
  • Check the patient group. Numbers for first-time (primary) augmentation are lower than for revision surgery.
  • Remember that no study has compared these brands head to head. Each study was run separately, in different years, and sponsored by the manufacturer.

Keeping an Eye on Your Implants

Breast implants are not lifetime devices, but there is no rule that they must be replaced every 10 years. Replacement or removal may be needed if an implant ruptures, capsular contracture develops, or another concern comes up.

My recommendation is an ultrasound 5 to 6 years after surgery and every 3 years after that. An MRI is indicated if the ultrasound result is unclear. The ultrasound can often be done at the same time as your regular breast cancer screening. If it is, ask the ordering physician to note on the prescription that the integrity of your breast implants should be checked.

My Perspective as a Surgeon and Motiva Investigator

Before September 2024, three manufacturers had FDA approval to sell silicone breast implants in the U.S.: Allergan, Mentor and Sientra. I used mostly Allergan, and I have experience with Mentor and Sientra as well. In September 2024, Motiva became the fourth FDA-approved silicone breast implant.

I was a principal investigator in the Motiva U.S. FDA clinical trial, which began in May 2018, so I have followed these implants in my own patients for years. In my practice I have shifted toward Motiva implants, and they are the implants I use for Preservé® breast augmentation. I still offer my patients a choice. In my opinion, Motiva offers the most natural-feeling breast (my spouse Amy has had Motiva implants since 2018), and its safety data so far is the most encouraging of the four brands. I believe that over time this will also make Motiva the more cost-effective choice.

Frequently Asked Questions

DISCLOSURE

Disclosure: Dr. Epstein is a paid investigator in the Motiva U.S. FDA clinical trial and is compensated by Establishment Labs to train surgeons on the Preservé® technique. Dr. Epstein owns stock in Establishment Labs.

References

  1. Spear SL, Murphy DK. Natrelle Round Silicone Breast Implants: Core Study Results at 10 Years. Plast Reconstr Surg. 2014;133(6):1354-1361. PMID: 24867717. https://doi.org/10.1097/PRS.0000000000000021
  2. Caplin DA, Calobrace MB, Wixtrom RN, Estes MM, Canady JW. MemoryGel Breast Implants: Final Safety and Efficacy Results after 10 Years of Follow-Up. Plast Reconstr Surg. 2021;147(3):556-566. PMID: 33620918. https://doi.org/10.1097/PRS.0000000000007635
  3. Sientra, Inc. Silicone Gel Breast Implants Patient Educational Brochure: Breast Augmentation. Revised January 3, 2023 (10-year Core Study data).
  4. Glicksman C, Wolfe A, McGuire P. The Study of the Safety and Effectiveness of Motiva SmoothSilk Silicone Gel-filled Breast Implants in Patients Undergoing Primary and Revisional Breast Augmentation: 5-Year Clinical Data. Aesthet Surg J. 2026;46(3):319-328. https://doi.org/10.1093/asj/sjaf245
  5. Glicksman C, Wolfe A, McGuire P. The Study of the Safety and Effectiveness of Motiva SmoothSilk Silicone Gel-Filled Breast Implants in Patients Undergoing Primary and Revisional Breast Augmentation: Three-Year Clinical Data. Aesthet Surg J. 2024;44(12):1273-1285. PMID: 39331509. https://doi.org/10.1093/asj/sjae134

Related Pages

Disclosure: Dr. Epstein is a paid investigator in the Motiva U.S. FDA clinical trial and is compensated by Establishment Labs to train surgeons on the Preservé technique. Dr. Epstein owns stock in Establishment Labs.

Chapters – Breast Augmentation Guide

Ready to Schedule Your Appointment?

We would love to discuss your options with you! Click on the button below to fill out a form, and a member of our team will be in touch with you shortly.

footeroffice img e1

Office Hours

Monday - Friday: 9am - 5pm

Accessibility Toolbar

Scroll to Top